McInnes Iain B相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Corrigendum to Bimekizumab treatment in biologic DMARD-naïve patients with active psoriatic arthritis: 52-week efficacy and safety results from the phase III, randomised, placebo-controlled, active reference BE OPTIMAL study Ann Rheum Dis. 2023;82:1404-1414

关于在未接受过生物制剂DMARD治疗的活动性银屑病关节炎患者中应用Bimekizumab治疗的更正：来自III期随机、安慰剂对照、活性参考BE OPTIMAL研究的52周疗效和安全性结果 Ann Rheum Dis. 2023;82:1404-1414

期刊:Annals of the Rheumatic Diseases

影响因子:20.6

doi:10.1016/j.ard.2025.05.013

Ritchlin, Christopher T; Coates, Laura C; McInnes, Iain B; Mease, Philip J; Merola, Joseph F; Tanaka, Yoshiya; Asahina, Akihiko; Gossec, Laure; Gottlieb, Alice B; Warren, Richard B; Ink, Barbara; Bajracharya, Rajan; Shende, Vishvesh; Coarse, Jason; Landewé, Robert B M

发表日期：2026

文献求助收藏

Impact of dactylitis and enthesitis resolution on disease control in guselkumab-treated psoriatic arthritis patients with TNFi-IR: COSMOS post hoc analysis

古塞库单抗治疗的TNFi-IR银屑病关节炎患者中，指炎和附着点炎消退对疾病控制的影响：COSMOS事后分析

期刊:Rheumatology

影响因子:4.4

doi:10.1093/rheumatology/keaf490

Marzo-Ortega, Helena; McInnes, Iain B; Sharaf, Mohamed; Zabotti, Alen; Rampakakis, Emmanouil; McGonagle, Dennis; Abogamal, Ahmed; Richette, Pascal; Schett, Georg

发表日期：2026

文献求助收藏

Guselkumab Improves Patient-Reported Outcomes Among Participants with Psoriatic Arthritis and Inadequate Response to Tumor Necrosis Factor Inhibitors in the COSMOS Study

在 COSMOS 研究中，古塞库单抗改善了对肿瘤坏死因子抑制剂反应不足的银屑病关节炎患者的患者报告结局

期刊:Rheumatology and Therapy

影响因子:2.9

doi:10.1007/s40744-025-00821-2

Gossec, Laure; Baraliakos, Xenofon; Galloway, James; Oke, Vilija; Sfikakis, Petros; Rampakakis, Emmanouil; Sharaf, Mohamed; Lavie, Frederic; McInnes, Iain B

发表日期：2026

文献求助收藏

Patient-reported outcomes as early warning signs of flare following drug cessation in rheumatoid arthritis

患者报告结局作为类风湿性关节炎停药后病情复发的早期预警信号

期刊:RMD Open

影响因子:4.7

doi:10.1136/rmdopen-2025-005442

Gumber, Leher; Rayner, Fiona; Bigirumurame, Theophile; Dyke, Bernard; Melville, Andrew; Kerrigan, Sean; McGucken, Andrew; Naamane, Najib; Prichard, Jonathan; Buckley, Christopher D; Filer, Andrew; McInnes, Iain B; Raza, Karim; Siebert, Stefan; Wason, James Ms; Ng, Wan-Fai; Anderson, Amy E; Isaacs, John D; Baker, Kenneth F; Pratt, Arthur G

发表日期：2025

文献求助收藏

Targeting the IL-17A pathway for therapy in early-stage tendinopathy.

靶向IL-17A通路治疗早期肌腱病

期刊:RMD Open

影响因子:4.7

doi:10.1136/rmdopen-2024-004729

Millar Neal L, McInnes Iain B, Kolbinger Frank, Raulf Friedrich, Akbar Moeed, Li Yufei, Beckmann Nicolau, Accart Nathalie, Leupin Olivier, Calonder Claudio, Schieker Matthias, Kneissel Michaela, Bruns Christian, Siegel Richard M, Weber Eckhard

发表日期：2025

文献求助收藏

Challenges and Opportunities in Psoriatic Disease: An Integrated View of the Future

银屑病面临的挑战与机遇：对未来的综合展望

期刊:Journal of Rheumatology

影响因子:3.4

doi:10.3899/jrheum.2025-0264

Chinchay, Lyn; Song, Kaiyang; Stark, Jeffrey; Ward, Nicole L; McInnes, Iain B

发表日期：2025

文献求助收藏

Correction: Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies

更正：比美珠单抗治疗银屑病关节炎患者的安全性和有效性：两项3期研究的2年结果

期刊:Rheumatology and Therapy

影响因子:2.9

doi:10.1007/s40744-025-00761-x

Mease, Philip J; Merola, Joseph F; Tanaka, Yoshiya; Gossec, Laure; McInnes, Iain B; Ritchlin, Christopher T; Landewé, Robert B M; Asahina, Akihiko; Ink, Barbara; Heinrichs, Andrea; Bajracharya, Rajan; Shende, Vishvesh; Coarse, Jason; Coates, Laura C

发表日期：2025

文献求助收藏

Summary of Research: Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies

研究总结：比美珠单抗治疗银屑病关节炎患者的安全性和有效性：两项3期研究的2年结果

期刊:Rheumatology and Therapy

影响因子:2.9

doi:10.1007/s40744-025-00764-8

Mease, Philip J; Merola, Joseph F; Tanaka, Yoshiya; Gossec, Laure; McInnes, Iain B; Ritchlin, Christopher T; Landewé, Robert B M; Asahina, Akihiko; Ink, Barbara; Heinrichs, Andrea; Bajracharya, Rajan; Shende, Vishvesh; Coarse, Jason; Coates, Laura C

发表日期：2025

文献求助收藏

Long-term safety and efficacy of anti-GM-CSF otilimab in patients with rheumatoid arthritis: long-term extension of three phase 3 randomised trials (contRAst X)

抗 GM-CSF 奥替利单抗治疗类风湿性关节炎患者的长期安全性和有效性：三项 3 期随机试验的长期扩展研究 (contRAst X)

期刊:BMJ Open

影响因子:2.3

doi:10.1136/bmjopen-2024-088869

Weinblatt, Michael E; Taylor, Peter C; McInnes, Iain B; Atsumi, Tatsuya; Strand, Vibeke; Takeuchi, Tsutomu; Bracher, Marguerite; Brooks, David; Curtis, Paula; Gupta, Anubha; Nijhawan, Rina; O'Shea, Ciara; Rayner, Kirsty; Saurigny, Didier; Shelton, Celia; Wang, Millie; Wang, Reena; Fleischmann, Roy M

发表日期：2025

文献求助收藏

Clinical predictors of flare and drug-free remission in rheumatoid arthritis: preliminary results from the prospective BIO-FLARE experimental medicine study

类风湿性关节炎病情复发和无药缓解的临床预测因素：前瞻性 BIO-FLARE 实验医学研究的初步结果

期刊:BMJ Open

影响因子:2.3

doi:10.1136/bmjopen-2024-092478

Rayner, Fiona; Hiu, Shaun; Melville, Andrew; Bigirumurame, Theophile; Anderson, Amy; Dyke, Bernard; Kerrigan, Sean; McGucken, Andrew; Prichard, Jonathan; Shahrokhabadi, Mohadeseh Shojaei; Hilkens, Catharien M U; Buckley, Christopher D; McInnes, Iain B; Ng, Wan-Fai; Goodyear, Carl; Teare, Dawn; Filer, Andrew; Siebert, Stefan; Raza, Karim; Pratt, Arthur; Baker, Kenneth F; Isaacs, John

发表日期：2025

文献求助收藏